港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

华昊中天医药-B

9.410

+0.4104.56%

成交量：78.88万

成交额：740.46万

市值：34.31亿

市盈率：-21.14

高：9.540

开：9.160

低：9.080

收：9.000

52周最高：39.500

52周最低：4.280

股本：3.65亿

香港流通股本：2.17亿

量比：2.44

换手率：0.36%

股息：- -

股息率：- -

每股收益(LYR):-0.445

净资产收益率：-18.99%

总资产收益率：-12.47%

市净率：3.97

市盈率(LYR):-21.14

市销率: 43.74

数据加载中...

总览公司新闻公告

医药股继续走强药明生物(02269)涨7.73% 国家医保局为脑机接口医疗服务价格单独立项

华昊中天医药-B03月10日主力净流出15万元散户资金买入

华昊中天医药-B获纳入恒生综合指数成份股

《盈警》华昊中天医药(02563.HK)亏损预减半年最多蚀1.5亿人民币

阿斯达克财经

【华昊中天医药-B(02563.HK)发盈警，预期年度净亏损1.46亿元至约1.51亿元】华昊中天医药-B(02563.HK)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。

华昊中天医药-B(02563)发盈警，预期年度净亏损1.46亿元至约1.51亿元

华昊中天医药撤回两笔投资款项

华昊中天医药-B(02563)获纳入恒生综合指数有望成为港股通标的

华昊中天医药(02563.HK)优替德隆胶囊II/ III期临床研究获FDA批准

阿斯达克财经

华昊中天医药-B(02563)：美国食品药品管理局批准优替德隆胶囊一线治疗晚期胃癌II/III期国际多中心临床研究

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02563/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02563","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02563\",,,,,undefined,":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"华昊中天医药-B","latestPrice":9.41,"timestamp":1756109316480,"preClose":9,"halted":0,"volume":788800,"delay":0,"floatShares":216720857,"shares":364588000,"eps":-0.44523122212240757,"marketStatus":"未开盘","change":0.41,"latestTime":"08-25 16:08:36","open":9.16,"high":9.54,"low":9.08,"amount":7404624,"amplitude":0.051111,"askPrice":9.41,"askSize":6800,"bidPrice":9.38,"bidSize":800,"shortable":0,"etf":0,"ttmEps":-0.44523122212240757,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756171800000},"marketStatusCode":0,"adr":0,"listingDate":1730304000000,"exchange":"SEHK","adjPreClose":9,"openAndCloseTimeList":[[1756085400000,1756094400000],[1756098000000,1756108800000]],"volumeRatio":2.441198,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02563\",,,,,undefined,":{"symbol":"02563","floatShares":216720857,"roa":"-12.47%","roe":"-18.99%","lyrEps":-0.445225,"volumeRatio":2.441198,"shares":364588000,"dividePrice":0,"high":9.54,"amplitude":0.051111,"preClose":9,"low":9.08,"week52Low":4.28,"pbRate":"3.97","psRate":"43.74","week52High":39.5,"institutionHeld":0,"latestPrice":9.41,"committee":-0.789474,"eps":-0.4452248494317072,"divideRate":0,"volume":788800,"delay":0,"ttmEps":-0.4452248494317072,"open":9.16,"prevYearClose":19.7,"prevWeekClose":9,"prevMonthClose":7.88,"prevQuarterClose":4.41,"fiveDayClose":8.7,"twentyDayClose":7.96,"sixtyDayClose":4.41,"earningDate":1756310400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02563\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02563","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-06-30","symbol":"02563","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1751247000000,"name":null,"time":"盘前","dateTimestamp":1751212800000,"actualEps":null},{"date":"2025-03-31","symbol":"02563","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"盘前","dateTimestamp":1743350400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02563\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02563\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1734537600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02563\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02563","date":"2025-08-22","current":-12.467667,"percent":0.49,"low":-63.892303,"twenty":-36.610392,"median":-12.190608,"eighty":-7.916058,"high":-7.737104,"avg":-23.026296,"sd":17.087875,"marketCap":1950487713},"quantilePoints":[{"date":"2024-11-01","current":-45.939002,"twenty":-42.207558,"median":-36.610392,"eighty":-34.727382,"marketCap":9515746800},{"date":"2024-11-08","current":-50.657086,"twenty":-48.301262,"median":-46.125418,"eighty":-40.341836,"marketCap":10445446200},{"date":"2024-11-15","current":-51.735366,"twenty":-51.259815,"median":-49.659484,"eighty":-46.008352,"marketCap":10554822600},{"date":"2024-11-22","current":-51.670488,"twenty":-51.75324,"median":-50.936861,"eighty":-46.12281,"marketCap":10536593200},{"date":"2024-11-29","current":-50.005514,"twenty":-51.751568,"median":-51.216637,"eighty":-46.188646,"marketCap":10190234600},{"date":"2024-12-06","current":-53.261904,"twenty":-52.309165,"median":-51.551619,"eighty":-47.62215,"marketCap":10828263600},{"date":"2024-12-13","current":-56.152393,"twenty":-53.128108,"median":-51.673125,"eighty":-49.762114,"marketCap":11393375000},{"date":"2024-12-20","current":-57.66573,"twenty":-54.870186,"median":-51.763763,"eighty":-49.951841,"marketCap":11648586600},{"date":"2024-12-27","current":-56.987991,"twenty":-56.152393,"median":-51.943964,"eighty":-50.005514,"marketCap":11502751400},{"date":"2025-01-03","current":-29.160861,"twenty":-55.458441,"median":-51.76237,"eighty":-46.238834,"marketCap":5891742080},{"date":"2025-01-10","current":-29.88764,"twenty":-55.141356,"median":-51.671807,"eighty":-37.690323,"marketCap":6015702000},{"date":"2025-01-17","current":-26.098924,"twenty":-54.634915,"median":-51.456455,"eighty":-29.807432,"marketCap":5257358960},{"date":"2025-01-24","current":-31.83595,"twenty":-54.024096,"median":-50.936861,"eighty":-29.486496,"marketCap":6453207600},{"date":"2025-01-28","current":-29.272366,"twenty":-53.898416,"median":-50.551705,"eighty":-29.486183,"marketCap":5964659680},{"date":"2025-02-07","current":-27.891403,"twenty":-53.763486,"median":-49.916059,"eighty":-28.779902,"marketCap":5651114000},{"date":"2025-02-14","current":-27.724819,"twenty":-53.195006,"median":-46.201193,"eighty":-28.045447,"marketCap":5614655200},{"date":"2025-02-21","current":-31.716408,"twenty":-52.922578,"median":-45.939002,"eighty":-28.200859,"marketCap":6445915840},{"date":"2025-02-28","current":-28.761543,"twenty":-52.84984,"median":-36.099768,"eighty":-28.259952,"marketCap":5826116240},{"date":"2025-03-07","current":-27.678496,"twenty":-52.618251,"median":-32.29046,"eighty":-28.259952,"marketCap":5629238720},{"date":"2025-03-14","current":-19.855324,"twenty":-52.427717,"median":-31.776179,"eighty":-27.893524,"marketCap":4039635040},{"date":"2025-03-21","current":-15.488933,"twenty":-51.9516,"median":-30.932826,"eighty":-27.594014,"marketCap":3150040320},{"date":"2025-03-28","current":-9.592432,"twenty":-51.908202,"median":-29.673915,"eighty":-27.348197,"marketCap":1946899920},{"date":"2025-04-03","current":-7.937518,"twenty":-51.765156,"median":-29.469494,"eighty":-26.098924,"marketCap":1607833080},{"date":"2025-04-11","current":-7.990601,"twenty":-51.76237,"median":-29.160861,"eighty":-21.966366,"marketCap":1607833080},{"date":"2025-04-17","current":-7.971477,"twenty":-51.740767,"median":-28.859539,"eighty":-19.722121,"marketCap":1607833080},{"date":"2025-04-25","current":-7.964599,"twenty":-51.698021,"median":-28.761543,"eighty":-16.327761,"marketCap":1607833080},{"date":"2025-05-02","current":-7.947706,"twenty":-51.67207,"median":-28.684662,"eighty":-12.879685,"marketCap":1607833080},{"date":"2025-05-09","current":-7.892301,"twenty":-51.665747,"median":-28.653449,"eighty":-9.667878,"marketCap":1607833080},{"date":"2025-05-16","current":-7.828344,"twenty":-51.608717,"median":-28.420136,"eighty":-7.99153,"marketCap":1607833080},{"date":"2025-05-23","current":-7.804998,"twenty":-51.422884,"median":-28.295023,"eighty":-7.977687,"marketCap":1607833080},{"date":"2025-05-30","current":-7.770834,"twenty":-51.274208,"median":-28.099009,"eighty":-7.965975,"marketCap":1607833080},{"date":"2025-06-06","current":-7.751059,"twenty":-51.104727,"median":-27.891403,"eighty":-7.948076,"marketCap":1607833080},{"date":"2025-06-13","current":-7.747995,"twenty":-50.614934,"median":-27.692071,"eighty":-7.919515,"marketCap":1607833080},{"date":"2025-06-20","current":-7.763212,"twenty":-50.358163,"median":-27.513301,"eighty":-7.892411,"marketCap":1607833080},{"date":"2025-06-27","current":-7.741532,"twenty":-49.987623,"median":-27.370929,"eighty":-7.828813,"marketCap":1607833080},{"date":"2025-07-04","current":-11.83634,"twenty":-49.916059,"median":-26.913642,"eighty":-7.828344,"marketCap":1863799370},{"date":"2025-07-11","current":-10.622116,"twenty":-49.659484,"median":-25.451597,"eighty":-7.830688,"marketCap":1670917807},{"date":"2025-07-18","current":-10.713174,"twenty":-46.263928,"median":-22.166181,"eighty":-7.835505,"marketCap":1683921058},{"date":"2025-07-25","current":-11.004065,"twenty":-46.138458,"median":-20.500443,"eighty":-7.892301,"marketCap":1735934064},{"date":"2025-08-01","current":-10.726899,"twenty":-46.112378,"median":-18.6504,"eighty":-7.892301,"marketCap":1681753850},{"date":"2025-08-08","current":-11.168953,"twenty":-45.939002,"median":-15.488933,"eighty":-7.892849,"marketCap":1755438941},{"date":"2025-08-15","current":-11.738095,"twenty":-37.960306,"median":-13.174334,"eighty":-7.893093,"marketCap":1842127284},{"date":"2025-08-22","current":-12.467667,"twenty":-36.610392,"median":-12.190608,"eighty":-7.916058,"marketCap":1950487713}],"updateTime":1756130869717},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02563\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519180728","title":"医药股继续走强 药明生物(02269)涨7.73% 国家医保局为脑机接口医疗服务价格单独立项","url":"https://stock-news.laohu8.com/highlight/detail?id=2519180728","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519180728?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 09:58","pubTimestamp":1741917523,"startTime":"0","endTime":"0","summary":"根据麦肯锡估算，预计在2030—2040年间，全球脑机接口在医疗领域应用的潜在市场规模有望达到400亿—1450亿美元，其中严肃医疗应用的潜在市场规模介于150亿—850亿美元，而消费医疗应用的潜在市场规模介于250亿—600亿美元。另外，近期多家医药头部企业宣布接入AI大模型，医药行业有望迎来新机遇。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955039","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","06990","03933","LU2125910500.SGD","BK1589","LU0516423174.USD","02268","LU0320764599.SGD","02563","LU0051755006.USD","LU1242518857.USD","LU0823426480.USD","LU0359202008.SGD","BK1161","LU0516423091.SGD","BK1515","LU0572944931.SGD","LU0708995583.HKD","02172","LU0979878070.USD","LU1688375341.USD","00853","BK1100","LU0307460666.USD","LU0326950275.SGD","LU2242644610.SGD","LU0456827905.SGD","02269","LU1880383366.USD","LU0456846285.SGD","09939","01951","SG9999002562.SGD","BK1574","BK1610","LU0359201612.USD","BK1617","LU0348735423.USD","LU0856984785.SGD","LU0348825331.USD","BK1597","02252","BK1585","159938","BK1576","LU0196878994.USD","02359","01302","LU0039217434.USD","LU0819121731.USD"],"gpt_icon":0},{"id":"2518210397","title":"华昊中天医药-B03月10日主力净流出15万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518210397?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 16:16","pubTimestamp":1741594570,"startTime":"0","endTime":"0","summary":"03月10日, 华昊中天医药-B股价跌19.04%，报收12.50元，成交金额363万元，换手率0.13%，振幅15.03%，量比2.78。华昊中天医药-B今日主力资金净流出15万元，上一交易日主力净流出0万元。该股近5个交易日下跌22.26%，主力资金累计净流出15万元；近20日主力资金累计净流入249万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170118a269ba8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170118a269ba8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2514029968","title":"华昊中天医药-B获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029968","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514029968?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 08:20","pubTimestamp":1740529200,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华昊中天医药-B（02563）发布公告，根据恒生指数有限公司于2025年2月21日宣布的指数检讨结果，公司已获恒生指数有限公司选定并将纳入恒生综合指数成份股。该变动将于2025年3月7日收市后实施并于2025年3月10日起生效。\n　　董事会认为，获纳入恒生综合指数反映资本市场对公司业务表现及价值的高度认可，将有助扩大股东基础并增加其股份交易的流通性，从而提高公司于资本市场的投资价值及声誉。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-26/doc-inemuerm3863117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09939","BK1161","HSCI","02563","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2514259019","title":"《盈警》华昊中天医药(02563.HK)亏损预减  半年最多蚀1.5亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2514259019","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514259019?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 00:15","pubTimestamp":1740500100,"startTime":"0","endTime":"0","summary":"华昊中天医药－Ｂ(02563.HK) 发盈警，预计2024年度净亏损介乎1.46亿至1.51亿人民币，相较2023年度净亏损1.9亿人民币。亏损减少主要受惠于产品市场渗透提高导致销售收入增长、产品生产工艺优化所带来的销售成本降低以及严格控制销售开支带来的销售费用减少。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180419170906667_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180419170906667_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1420114/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1515","02563","BK1161","159938","BK1574"],"gpt_icon":0},{"id":"2514094708","title":"【华昊中天医药-B(02563.HK)发盈警，预期年度净亏损1.46亿元至约1.51亿元】华昊中天医药-B(02563.HK)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514094708","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514094708?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 21:56","pubTimestamp":1740491793,"startTime":"0","endTime":"0","summary":"华昊中天医药-B(02563.HK)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25215648383396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02563","BK1574","BK1515","09939","BK1161","159938"],"gpt_icon":0},{"id":"2514109423","title":"华昊中天医药-B(02563)发盈警，预期年度净亏损1.46亿元至约1.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514109423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514109423?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 21:46","pubTimestamp":1740491197,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。董事会认为，上述亏损减少主要得益于产品市场渗透提高导致销售收入增长、产品生产工艺优化所带来的销售成本降低以及严格控制销售开支所带来的销售费用减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","BK1574","02563","09939","159938"],"gpt_icon":0},{"id":"2514098970","title":"华昊中天医药撤回两笔投资款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2514098970","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514098970?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:57","pubTimestamp":1740484646,"startTime":"0","endTime":"0","summary":"2月25日，华昊中天医药-B发布公告，指出公司于2024年11月22日和11月25日分别认购了两家不同基金公司的保本低风险基金产品，投资金额为3800万元和2200万元。公告日期时，公司已将这两笔认购全部撤回并收回了全部款项。公司高层在综合评估后认为，这些投资的条款公平合理，符合公司的整体利益。公司强调这是无心之失，并表示已全数收回投资款项，未来不会影响首次公开发售所得款项的正常使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225195809962fcc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225195809962fcc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02563","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2513266263","title":"华昊中天医药-B(02563)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2513266263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513266263?lang=zh_cn&edition=fundamental","pubTime":"2025-02-21 19:18","pubTimestamp":1740136715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月21日，恒生指数公司公布最新季检结果，其中华昊中天医药-B获纳入恒生综合指数成份股，所有变动将于2025年3月7日(星期五)收市后实施并于2025年3月10日(星期一)起生效。据中信证券研报估算，中华昊中天医药-B有可能被纳入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1515","HSCEI","BK1161","09939","HSCI","YANG","159938","BK1574","02563"],"gpt_icon":0},{"id":"2509323951","title":"华昊中天医药(02563.HK)优替德隆胶囊II/ III期临床研究获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2509323951","media":"阿斯达克财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509323951?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 00:45","pubTimestamp":1738773900,"startTime":"0","endTime":"0","summary":"华昊中天医药－Ｂ(02563.HK) 公布，集团的重要海外管线之一，优替德隆胶囊“UTD2”联合卡培他滨和奥沙利铂一线治疗PD -L1阴性的局部晚期或转移性胃或胃食管交界处腺癌的国际多中心II/ III期注册临床研究“BG 02 -2404”已获美国食品药品管理局“FDA”批准。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241023093229939_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241023093229939_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1415083/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1161","02563","BK1515","BK1574","159938"],"gpt_icon":0},{"id":"2509280605","title":"华昊中天医药-B(02563)：美国食品药品管理局批准优替德隆胶囊一线治疗晚期胃癌II/III期国际多中心临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280605","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509280605?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 22:59","pubTimestamp":1738767552,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B 发布公告，本集团的重要海外管线之一，优替德隆胶囊联合卡培他滨和奥沙利铂一线治疗PD-L1阴性的局部晚期或转移性胃或胃食管交界处腺癌的国际多中心II/III期注册临床研究已获得美国食品药品管理局的批准。UTD2也因此获得了FDA授予的治疗晚期胃癌孤儿药资格认定。BG02-2404是本公司针对UTD2开展的首个国际多中心II/III期注册临床研究，旨在进一步夯实本公司国际化开发战略的实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1246312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK1161","02563","III","159938","09939","BK4134"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":50,"code":"91000000","status":"200"}]}}